Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global viral inactivation market size reached US$ 577.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,028.4 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2022-2028.
Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.
Viral Inactivation Market Trends:
Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Reagents and Kits
Systems
Services
Breakup by Application:
Vaccines and Therapeutics
Stem Cell Products
Blood and Blood Products
Tissue and Tissue Products
Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.
Key Questions Answered in This Report:
How has the global viral inactivation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global viral inactivation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global viral inactivation market and who are the key players?
What is the degree of competition in the industry?
Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.
Viral Inactivation Market Trends:
Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Reagents and Kits
Systems
Services
Breakup by Application:
Vaccines and Therapeutics
Stem Cell Products
Blood and Blood Products
Tissue and Tissue Products
Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.
Key Questions Answered in This Report:
How has the global viral inactivation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global viral inactivation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global viral inactivation market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL VIRAL INACTIVATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Systems
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Vaccines and Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Stem Cell Products
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood and Blood Products
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tissue and Tissue Products
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Cellular and Gene Therapy
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USE
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 CROs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Charles River Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Merck KGaA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Parker Hannifin Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Rad Source Technologies
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Sartorius AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 SGS SA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Terumo Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Texcell
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Vironova AB
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 WuXi AppTec
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL VIRAL INACTIVATION MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Systems
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Vaccines and Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Stem Cell Products
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood and Blood Products
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tissue and Tissue Products
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Cellular and Gene Therapy
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USE
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 CROs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Charles River Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Merck KGaA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Parker Hannifin Corp
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Rad Source Technologies
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Sartorius AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 SGS SA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Terumo Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Texcell
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Vironova AB
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 WuXi AppTec
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
LIST OF TABLES
Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Viral Inactivation Market: Competitive Structure
Table 7: Global: Viral Inactivation Market: Key Players
Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Viral Inactivation Market: Competitive Structure
Table 7: Global: Viral Inactivation Market: Key Players
LIST OF FIGURES
Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2022
Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2022
Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2022
Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2022
Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis
Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2022
Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2022
Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2022
Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2022
Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis
